According to POINT Biopharma's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 5.46636. At the end of 2023 the company had a P/S ratio of 2.89.
Year | P/S ratio | Change |
---|---|---|
2023 | 2.89 | -14.83% |
2022 | 3.40 | |
2021 | N/A |